Skip to main content
Live · TradingView
Back to the NewsWire

Biospace

Published September 15, 2026 · Updated September 16, 2026

BioVie Announces Topline Results from Phase 2 ADDRESS‑LC Trial Evaluating Bezisterim ...

Read the full story at Biospace

HT9425-24-1-0113. Opinions, interpretations, conclusions and recommendations in this press release are those of the author and are not necessarily.

Surfaced by this Google Alert

  • Psychedelic press release